POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,690 | -10.3% | 14,996 | -33.7% | 0.00% | – |
| Q2 2023 | $39,790 | -68.8% | 22,608 | -45.4% | 0.00% | – |
| Q1 2023 | $127,564 | +131.9% | 41,417 | +234.5% | 0.00% | – |
| Q1 2022 | $55,000 | -48.1% | 12,383 | -20.2% | 0.00% | – |
| Q4 2021 | $106,000 | -6.2% | 15,514 | 0.0% | 0.00% | – |
| Q3 2021 | $113,000 | -71.5% | 15,514 | -60.9% | 0.00% | – |
| Q2 2021 | $397,000 | -16.8% | 39,657 | -20.6% | 0.00% | -100.0% |
| Q1 2021 | $477,000 | +113.9% | 49,942 | +145.8% | 0.00% | – |
| Q4 2020 | $223,000 | +23.9% | 20,321 | 0.0% | 0.00% | – |
| Q3 2020 | $180,000 | – | 20,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |